" class="no-js "lang="en-US"> Anders Ullman - Medtech Alert
Wednesday, March 22, 2023
Anders Ullman

Anders Ullman

About Anders Ullman

Related Story

ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® for the Treatment of Lymphoma

December 21 2022

ADC Therapeutics SA and Swedish Orphan Biovitrum AB (Sobi) has announced the European Commission (EC) […]

Sobi Continues the R&D Transformation - Anders Ullman Appointed New Head of R&D

December 13 2021

Anders Ullman, M.D., Ph.D., currently a member of the Board of Directors of Sobi, will […]